Diagnosis requires 2 of 3 criteria: (1) Characteristic abdominal pain — epigastric, radiating to back. (2) Serum amylase or lipase >3× upper limit of normal. (3) Confirmatory cross-sectional imaging (CT/MRI).
🏷️Atlanta Classification 2012
| Severity | Definition | Mortality |
|---|
| Mild | No organ failure, no local/systemic complications | <1% |
| Mod–Severe | Transient organ failure (<48h) OR local complications | ~8% |
| Severe | Persistent organ failure (>48h) — single or multi-organ | 30–50% |
Local complications: Acute peripancreatic fluid collection, pancreatic pseudocyst, acute necrotic collection, walled-off necrosis (WON).
📊BISAP Score (0–5)
Score ≥3 = High Risk for Mortality
| Criterion | Threshold |
|---|
| BUN | >25 mg/dL (9 mmol/L) |
| Impaired mental status | GCS <15 or altered mentation |
| SIRS ≥2 criteria | See SIRS definition below |
| Age | >60 years |
| Pleural effusion | On imaging |
4–5
High Risk
>20% mortality
🦠SIRS Criteria — 2 or more = SIRS positive
| Parameter | Positive Threshold |
|---|
| Temperature | <36°C or >38°C |
| Heart Rate | >90 bpm |
| Respiratory Rate | >20/min or PaCO₂ <32 mmHg |
| WBC | <4 × 10⁹/L or >12 × 10⁹/L, or >10% bands |
Marshall Scoring (Organ Failure)
| System | Score ≥2 = Organ Failure |
|---|
| Respiratory | PaO₂/FiO₂ <300 |
| Cardiovascular | SBP <90 mmHg unresponsive to fluids |
| Renal | Creatinine >170 μmol/L |
📝Ranson Criteria
At Admission
- Age >55 years
- WBC >16 × 10⁹/L
- Blood glucose >11 mmol/L (non-diabetic)
- LDH >350 IU/L
- AST >250 IU/L
At 48 Hours
- Haematocrit fall >10%
- BUN rise >1.8 mmol/L
- Calcium <2 mmol/L
- PaO₂ <60 mmHg
- Base deficit >4 mEq/L
- Fluid sequestration >6L
Score ≥3 = severe AP. Each additional criterion above 3 significantly increases mortality.
🖥️CT Severity Index (CTSI / Balthazar)
Balthazar Grade (0–4 points)
| Grade | CT Findings | Points |
|---|
| A | Normal pancreas | 0 |
| B | Pancreatic enlargement only | 1 |
| C | Inflammation ± fat stranding | 2 |
| D | Single fluid collection | 3 |
| E | Multiple/distant fluid collections or gas | 4 |
Necrosis Score (0–6 points)
| Necrosis | Points |
|---|
| None | 0 |
| <30% | 2 |
| 30–50% | 4 |
| >50% | 6 |
CTSI = Balthazar + Necrosis. Score 7–10: 17× higher complication rate, 10× higher mortality vs score 0–3.
🔬Causes — GET SMASHED Mnemonic
GGallstones — Most common cause worldwide & GCC. Stone lodged at ampulla of Vater.
EEthanol — 2nd most common globally; culturally sensitive in GCC context
TTrauma — Blunt abdominal trauma; seat-belt injury
SSteroids — Prolonged systemic corticosteroid use
MMumps (viral) — and other viruses: Coxsackie B, CMV, HIV
AAutoimmune — IgG4-related, primary sclerosing cholangitis
SScorpion sting / Snake venom — relevant in GCC rural/desert settings
HHyperlipidaemia (Hypertriglyceridaemia >11 mmol/L) — rising incidence in GCC metabolic syndrome
EERCP — post-ERCP pancreatitis in 3–5% of cases
DDrugs — Azathioprine, furosemide, sulfonamides, valproate, didanosine
📋Modified Glasgow (PANCREAS) Score
NNeutrophils (WBC) >15 × 10⁹/L
CCalcium <2 mmol/L (corrected)
EEnzymes: LDH >600 IU/L or AST >200 IU/L
SSugar (glucose) >10 mmol/L (non-diabetic)
Score ≥3 within 48h = severe acute pancreatitis. Sensitivity ~60%, specificity ~85%.
Early aggressive intervention saves lives. The first 24–48h are critical. Fluid resuscitation, analgesia, and nutrition timing are the three pillars.
💧Fluid Resuscitation
Preferred: Hartmann's solution (Lactated Ringer's) — reduces SIRS vs normal saline. Avoid NS-induced hyperchloraemic acidosis.
Aggressive Early Phase (0–24h)
- 250–500 mL/hr IV bolus phase for haemodynamic instability
- Target: UO >0.5 mL/kg/hr, HR <120, MAP >65 mmHg
- Haematocrit as surrogate — aim Hct 35–44%
- Reassess every 4h with clinical parameters
Monitoring Parameters
| Parameter | Target / Frequency |
|---|
| Urine output | >0.5 mL/kg/hr — hourly via IDC |
| Heart rate | <120 bpm — hourly |
| Haematocrit | 35–44% — 6-hourly in severe AP |
| BUN/Creatinine | Trend downward — 12–24 hourly |
| Blood glucose | 6–10 mmol/L — 1–2 hourly in severe AP |
Caution: Over-resuscitation causes abdominal compartment syndrome. Reassess and de-escalate once haemodynamically stable.
💊Analgesia
Evidence update: Historical concern that morphine causes Oddi sphincter spasm is NOT supported by evidence. Opioids are safe and effective for AP analgesia.
Analgesic Approach
1
IV Morphine or Fentanyl
Morphine 2–4mg IV q2–4h PRN or patient-controlled analgesia (PCA). Fentanyl preferred in renal impairment.
2
Regular Paracetamol
1g IV/PO q6h as opioid-sparing adjunct. Continue throughout admission.
3
NSAIDs (with caution)
Avoid in renal impairment, haemodynamic instability, and elderly. Consider rectal diclofenac if tolerating PR route.
4
Epidural (severe refractory)
Thoracic epidural analgesia for severe AP with inadequate IV analgesia control.
Assess pain q2–4h using NRS 0–10. Document response and escalate if NRS >6 persists >1h.
🍽️Nutrition — NBM vs Early Enteral Nutrition
ESPEN 2020 Guideline: Early enteral nutrition within 24–48h is preferred for moderate–severe and severe AP. NOT routine NBM.
Mild AP
- Oral diet can be started when pain is tolerated
- Low-fat, low-residue soft diet initially
- No benefit from prolonged NBM
- Progress to normal diet as tolerated
Moderate–Severe / Severe AP
- Nasojejunal (NJ) tube preferred over nasogastric for severe AP
- Start low rate (10–20 mL/hr) and titrate
- Maintains gut mucosal integrity, reduces bacterial translocation
- Reduces infectious complications vs parenteral nutrition
NJ Tube Nursing Care
- Confirm position via X-ray before feeding (tip past ligament of Treitz)
- Flush with 30 mL water q4h and before/after medications
- Monitor for aspiration, residual volumes (if any doubt)
- Elevate HOB 30–45° during feeding
- Monitor tolerance: nausea, distension, diarrhoea
Parenteral Nutrition (PN)
- Only if EN not feasible or not tolerated after 5–7 days
- Central line (PICC or CVC) required
- Monitor BGLS, electrolytes, LFTs closely
- Higher infection risk — strict aseptic technique
🔭ERCP — Biliary Pancreatitis
Indication: Biliary AP with concurrent cholangitis or persistent biliary obstruction (rising bilirubin/ALP). NOT for mild biliary AP without obstruction.
- Urgent ERCP within 24h for AP with acute cholangitis
- ERCP within 72h for AP with persistent biliary obstruction
- Sphincterotomy + stone extraction
- Rectal indomethacin 100mg PR before/during ERCP to prevent post-ERCP pancreatitis
- Pancreatic duct stent for high-risk patients (prior PEP, difficult cannulation)
Cholecystectomy Timing
- Before discharge for mild gallstone AP (index admission)
- Within 6 weeks for moderate–severe AP once clinically improved
- Reduces recurrence risk by >70%
📈Blood Glucose Management
Stress Hyperglycaemia in AP
- Common even in non-diabetic patients due to glucagon release and insulin resistance
- BGLs 1–2 hourly in severe AP or with infusion running
- Target BGL: 6–10 mmol/L (avoid tight control — hypoglycaemia risk)
- IV insulin infusion if persistently >10 mmol/L
- Hypertriglyceridaemia-induced AP: insulin infusion also lowers triglycerides
Hypertriglyceridaemia-Induced AP
- TG >11.3 mmol/L diagnostic; target <5.6 mmol/L
- Insulin infusion (0.1–0.3 units/kg/hr) activates lipoprotein lipase
- Heparin activates lipoprotein lipase — used adjunctively
- Fibrates (fenofibrate) for long-term prevention
- Plasma exchange in refractory severe hypertriglyceridaemia
Severe Acute Pancreatitis: Persistent organ failure >48h. ICU transfer required if >2 organ systems failing. Mortality 30–50%. Necrotising pancreatitis carries highest risk.
🏥ICU Transfer Criteria
Transfer to ICU immediately if any of the following:
- Failure of >2 organ systems (Marshall score ≥2 in ≥2 systems)
- Persistent hypotension despite aggressive resuscitation
- SpO₂ <90% on high-flow oxygen or need for ventilation
- Oliguria/anuria unresponsive to fluids
- GCS <14 or rapid deterioration in mentation
- Worsening SIRS despite treatment
- Abdominal compartment syndrome (IAP >20 mmHg)
MODS Monitoring (q4–6h in ICU)
| System | Monitor | Intervention Threshold |
|---|
| Respiratory | SpO₂, ABG, RR | PaO₂/FiO₂ <300 |
| Cardiovascular | MAP, HR, lactate | MAP <65 mmHg |
| Renal | UO, creatinine, urea | UO <0.5 mL/kg/hr |
| Haematological | FBC, DIC screen | Plt <100, INR >1.5 |
| Hepatic | LFTs, bilirubin | Bilirubin >34 μmol/L |
🖥️Necrotising Pancreatitis
CT diagnosis: Areas of non-enhancement on contrast CT (>30% pancreatic parenchyma). Highest morbidity and mortality in AP.
Sterile Necrosis
- Manage conservatively if clinically stable
- Aggressive nutritional support (NJ tube)
- Antibiotics NOT indicated routinely
- Repeat CT in 3–4 weeks if not improving
Infected Necrosis — Clinical Features
- Clinical deterioration after initial improvement
- Fever, rising CRP, rising WBC after day 7
- Gas in necrosis on CT — pathognomonic sign
- FNA (fine needle aspiration) for Gram stain and culture if uncertain
Antibiotic Use
NOT routinely recommended for sterile necrosis. Reserve for infected necrosis — carbapenem (imipenem/meropenem) or fluoroquinolone + metronidazole. Duration: 4–6 weeks minimum.
⬆️Step-Up Approach — Infected / Symptomatic Necrosis
1
Conservative Management (weeks 0–4)
Antibiotics, NJ nutritional support, supportive care. Allow necrosis to liquefy and form organised collection (WON) — minimum 4 weeks from onset. Premature intervention has higher morbidity.
2
Percutaneous Catheter Drainage (PCD)
CT/US-guided drain insertion. First-line intervention for walled-off necrosis. Monitor drain output daily — note character (clear/cloudy/purulent), volume. Irrigation protocols as per surgeon order.
3
Endoscopic/Minimally Invasive Necrosectomy
Endoscopic transmural drainage (lumen-apposing metal stent — LAMS) or video-assisted retroperitoneal debridement (VARD). Preferred over open surgery — lower morbidity.
4
Open Surgical Necrosectomy
Last resort. Only if all above fail or patient has abdominal compartment syndrome or bleeding requiring laparotomy. Higher mortality and fistula risk. Post-op intensive monitoring essential.
🍽️Nutritional Support — Severe AP
- NJ tube preferred — start within 24–48h
- Polymeric feeds equivalent to semi-elemental in most patients
- Target: 25–35 kcal/kg/day; 1.2–1.5g protein/kg/day
- Parenteral nutrition only if EN not tolerated after 5–7 days
- Monitor daily fluid balance, BGL, electrolytes
- Zinc, selenium and other micronutrient supplementation
Early EN reduces infected necrosis, length of stay, and mortality compared to PN. Prioritise EN whenever feasible.
🩺Abdominal Compartment Syndrome
Intra-Abdominal Hypertension Grading
| Grade | IAP | Action |
|---|
| I | 12–15 mmHg | Vigilant monitoring |
| II | 16–20 mmHg | Fluid optimisation, decompressive measures |
| III | 21–25 mmHg | Interventional decompression |
| IV | >25 mmHg | Emergency decompression — ACS |
Nursing: Bladder Pressure Measurement
- Via urinary catheter with sterile technique
- Instil 25 mL saline, clamp 30–60 sec, measure in mmHg at end-expiration
- Patient supine, zero at mid-axillary line
- Measure 4–6 hourly in ICU with high suspicion
Chronic Pancreatitis (CP): Irreversible progressive destruction of pancreatic parenchyma — exocrine and endocrine insufficiency develop over time. Alcoholic CP most common globally and in GCC expat population.
📌TIGAR-O Classification — Causes of Chronic Pancreatitis
| Category | Cause | Notes |
|---|
| Toxic-Metabolic | Alcohol (most common), tobacco, hypercalcaemia, hyperlipidaemia, renal failure | Alcohol >80g/day for >5 years; synergistic with smoking |
| Idiopathic | Early-onset (<35y) or late-onset idiopathic CP | Tropical CP in South Asia — rare in GCC |
| Genetic | PRSS1, SPINK1, CFTR mutations | Hereditary pancreatitis — family history important |
| Autoimmune | Type 1 (IgG4) and Type 2 AIP | Responds to steroids — important not to miss |
| Recurrent/severe AP | Post-necrotic scarring from recurrent AP episodes | Common in GCC gallstone patients |
| Obstructive | Ductal obstruction from tumour, stricture, pancreas divisum | CT/MRCP essential to exclude malignancy |
🔬Exocrine Insufficiency (EPI)
Clinical Features
- Steatorrhoea — loose, pale, greasy, malodorous stools
- Weight loss despite adequate oral intake
- Fat-soluble vitamin deficiency (A, D, E, K)
- Malnutrition — muscle wasting, hypoalbuminaemia
- Osteoporosis (Vitamin D + K deficiency)
- Bloating, flatulence, abdominal cramps
Diagnosis
| Test | Threshold |
|---|
| Faecal elastase-1 | <200 μg/g stool = severe EPI; <100 μg/g = profound |
| 72h faecal fat | >7g/day on 100g fat diet = steatorrhoea |
| Serum fat-soluble vitamins | A, D, E, K levels — monitor 6-monthly |
💊PERT — Pancreatic Enzyme Replacement
Creon (pancrelipase) contains lipase, amylase, and protease in enteric-coated microspheres. Protects from gastric acid. Do NOT crush capsules or microspheres.
Dosing (Lipase Units)
| Meal Type | Dose |
|---|
| Main meals | 25,000–50,000 lipase units (Creon 25 × 1–2) |
| Snacks | Half main meal dose (10,000–25,000 units) |
| Liquid meals/enteral feeds | Titrate to response |
Key Nursing Points
- Timing: Take WITH or just before food — not after
- Capsules can be opened; sprinkle microspheres on acidic food (e.g. apple purée) — do not crush
- Swallow immediately after opening onto food — do not pre-prepare
- Adequate hydration to prevent fibrosing colonopathy (rare — very high doses in children)
- Review response at 2–4 weeks — adjust dose if stools improving
- Concomitant PPI improves efficacy (raises duodenal pH)
🩸Endocrine Insufficiency — Type 3c DM
Type 3c (pancreatogenic) DM: Both insulin AND glucagon deficiency — uniquely brittle diabetes with hypoglycaemia unawareness. Different from T1DM and T2DM.
Characteristics
- Hypoglycaemia unawareness — glucagon counter-regulation absent
- Variable insulin requirements
- Exocrine insufficiency + malabsorption affect glucose levels
- Exacerbated by alcohol and irregular eating patterns
- Higher risk of hypoglycaemia than T1DM
Management Priorities
- Avoid aggressive glycaemic targets — HbA1c 7–8% acceptable
- No sulphonylureas (risk of severe hypoglycaemia)
- Treat EPI first — improves glucose stability
- Insulin (basal-bolus) most effective; metformin may be used early
- Regular monitoring — CGM highly beneficial
- Patient education critical — hypoglycaemia recognition and management
🔥Pain Management — Chronic Pancreatitis
Analgesic Ladder
1
Non-opioid baseline
Paracetamol 1g QDS + NSAIDs (if tolerated, renal function adequate). Antioxidants — some evidence for pain reduction.
2
Weak opioids / adjuvants
Tramadol, pregabalin (neuropathic component), amitriptyline. PERT may reduce pain by reducing pancreatic stimulation.
3
Strong opioids
Transdermal fentanyl patch or oral morphine SR. Monitor for dependence, constipation. Addiction risk in CP is real — multidisciplinary review.
4
Interventional / surgical
Coeliac plexus block (EUS-guided). Endoscopic therapy (pancreatic duct stones/strictures). Surgical options: Frey procedure, Whipple's, total pancreatectomy + islet auto-transplant.
⚠️Complications of Chronic Pancreatitis
| Complication | Features / Management |
|---|
| Pseudocyst | Fluid collection without epithelial lining. Mostly resolve spontaneously; drain if symptomatic or infected. Endoscopic, percutaneous, or surgical drainage. |
| Ductal Dilation | Wirsung duct >3 mm. Main-duct IPMN must be excluded. Endoscopic stenting or surgery (Puestow) for pain relief. |
| Splenic Vein Thrombosis | Left-sided portal hypertension. Gastric varices (not oesophageal). Splenectomy if variceal bleeding occurs. |
| Malignant Transformation | 4–5% lifetime risk of pancreatic adenocarcinoma. Annual surveillance with EUS or MRCP for high-risk patients. |
| Complication | Features / Management |
|---|
| Bile Duct Stricture | Progressive jaundice, cholangitis risk. ERCP stenting vs hepaticojejunostomy. |
| Pancreatic Fistula | Ductal disruption → ascites or pleural effusion (high amylase). Conservative (NBM + octreotide) or ERCP stent. |
| Osteoporosis | Fat malabsorption → Vit D/K deficiency. DEXA scan baseline. Calcium + Vit D supplementation. |
| Malnutrition | Optimise PERT, dietary counselling (low-fat, high-protein, small frequent meals), nutritional supplementation. |
🔭ERCP Nursing Care
Pre-Procedure
- Confirm written informed consent — risks include post-ERCP pancreatitis (3–5%), perforation, bleeding, cholangitis
- NBM 4–6h (solids 6h, clear fluids 2h)
- IV cannula (18G minimum), allergy check, coagulation screen
- Baseline obs, SpO₂, ECG if indicated
- Remove dental prostheses, position supine or left lateral
- Rectal indomethacin 100mg — admin before/during ERCP in all patients (reduces PEP risk)
During Procedure (Sedation Monitoring)
- Continuous SpO₂, ETCO₂ (if capnography), BP, ECG, HR
- Propofol or midazolam + fentanyl conscious sedation
- O₂ via nasal cannula — maintain SpO₂ >95%
- Document radiation screening time, contrast used
- Airway management equipment available — resuscitation trolley present
Post-Procedure (2–4 hours minimum)
- Obs q15min × 4, then q30min × 2, then hourly
- Monitor for PEP: epigastric pain, nausea, vomiting, fever
- Serum amylase/lipase at 2–4h if symptomatic
- Discharge criteria: pain-free, haemodynamically stable, tolerating oral fluids, responsible adult to escort
🔬EUS-FNA / Pseudocyst Drainage
EUS-Guided FNA Nursing
- Similar sedation care to ERCP
- Bleeding risk higher — check INR, platelets beforehand (INR <1.5, Plt >50)
- Anticoagulants bridged or held per protocol
- ROSE (rapid on-site evaluation) if available — pathologist present
- Post-procedure: 4h observation, monitor for bleed, perforation, fever
- Delayed bleeding risk up to 24–48h — patient education essential
Endoscopic Cystgastrostomy (Pseudocyst Drainage)
- EUS-guided transmural drainage — LAMS (lumen-apposing metal stent) commonly used
- Post-drainage: monitor drain output daily (volume, character)
- Repeat CT at 4–6 weeks to confirm resolution
- Stent removal typically at 6–8 weeks once collapsed
- Signs of stent occlusion: recurrent pain, fever, rising inflammatory markers
- Antibiotics peri-procedural (co-amoxiclav or pip-taz per protocol)
🏥Whipple's Procedure (Pancreaticoduodenectomy) — Post-Operative Nursing
High-risk, complex surgery. Anastomotic complications are the primary cause of post-operative morbidity and mortality. Vigilant nursing observation is essential in the first 72–96h.
Key Complications — Definitions & Signs
| Complication | Features | Nurse Action |
|---|
| Postoperative Pancreatic Fistula (POPF) | Drain amylase >3× ULN on day 3+ with clinical impact | Document drain amylase daily, note output volume and character |
| Delayed Gastric Emptying (DGE) | NGT required >3 days or unable to tolerate oral intake by day 7 | Monitor NGT output, bowel sounds, nausea/vomiting — prokinetics PRN |
| Post-Pancreatectomy Haemorrhage (PPH) | Sentinel bleed from drain, haematemesis, or haemodynamic instability | Urgent call — activate massive haemorrhage protocol, urgent CT angiography |
| Bile Leak | Bile-stained drain fluid, rising bilirubin in drain | Document drain colour, bilirubin drain:serum ratio >3 = leak |
| Wound Infection / Dehiscence | Redness, heat, discharge, wound opening | Wound assessment q12h, sterile dressing technique |
Surgical Drain Management
- Jackson-Pratt or Blake drains — record output volume + character every shift
- Send drain fluid for amylase on post-op day 1 and day 3
- High amylase drain fluid (day 3+) = pancreatic fistula
- Irrigate drain only on surgical instruction
- Early drain removal (day 3–5 if amylase normal) reduces risk of infection
Routine Post-Op Monitoring
- BGL 1–2 hourly (new diabetes post-pancreatectomy common)
- Daily FBC, U&E, LFTs, CRP for first 5–7 days
- Liver drain (hepaticojejunostomy) monitoring for bile leak
- Early oral nutrition when DGE resolves — soft diet progressing
- PERT from first post-op meal — continue lifelong if total pancreatectomy
- VTE prophylaxis (LMWH + TED stockings) — high DVT/PE risk
💉Distal Pancreatectomy — Post-Op Care & Splenectomy Vaccines
Post-Op Monitoring
- Drain amylase (pancreatic stump fistula risk)
- BGL — partial or total exocrine/endocrine loss depending on extent
- Splenic hilum bleeding risk if splenectomy performed
- Left-sided pleural effusion — common, monitor SpO₂
- DVT prophylaxis essential
Post-Splenectomy Vaccination Protocol
OPSI (Overwhelming Post-Splenectomy Infection): Life-threatening. Encapsulated organisms — Pneumococcus, Hib, Meningococcus.
| Vaccine | Timing |
|---|
| Pneumococcal (PCV13 + PPSV23) | ≥2 weeks before surgery (elective) or within 2 weeks post-op |
| Haemophilus influenzae B (Hib) | Same timing |
| Meningococcal (MenACWY + MenB) | Same timing |
| Annual influenza | Yearly |
| Lifelong penicillin V / amoxicillin | 250–500mg BD — document and reinforce |
GCC-Specific Practice: Understanding the regional epidemiology, cultural context, and healthcare delivery nuances is essential for providing optimal pancreatitis care in Gulf healthcare settings.
🫙Gallstone Pancreatitis — GCC Epidemic
Gallstone disease is the leading cause of AP in GCC — driven by high-fat diet, obesity epidemic, metabolic syndrome, and sedentary lifestyle. Rates significantly higher than global average.
Risk Factors in GCC Population
- Obesity — BMI >30 highly prevalent in KSA, UAE, Kuwait (>35% adult population)
- Type 2 diabetes — high-fat traditional and fast-food diet transition
- Female gender + multiparity + rapid weight loss
- Prolonged fasting (Ramadan) — gallstone formation/bile sludge
- Hypercholesterolaemia common in GCC metabolic syndrome
Prevention Message for GCC Patients
- Low-fat diet — culturally adapt: reduce clarified butter (samn), deep-frying
- Slow, gradual weight loss — rapid loss increases gallstone risk
- Cholecystectomy after first gallstone AP episode — before discharge
- Ursodeoxycholic acid if surgery deferred (e.g., Ramadan planning)
🤫Alcohol-Related Pancreatitis — Cultural Sensitivity
Clinical reality: Alcohol consumption exists in GCC populations despite legal/religious restrictions — particularly in expatriate communities. Accurate history is essential for diagnosis and management.
History-Taking Approach
- Private, non-judgmental environment — never in presence of family initially
- Use neutral, clinical language: "Some medications and substances can affect the pancreas — can you tell me about anything you've taken recently?"
- Normalise: "We ask all patients about this as part of routine care"
- AUDIT-C screening tool in clinical documentation (not patient-visible chart)
- Confidentiality — explain local legal context and hospital policy clearly
- Interpreter service — maintain interpreter confidentiality obligations
Management Considerations
- Wernicke's encephalopathy risk — IV thiamine before IV dextrose
- Alcohol withdrawal monitoring (CIWA score) — benzodiazepine protocol
- Harm reduction counselling — addiction services referral where available
📊Hypertriglyceridaemia-Induced Pancreatitis — Rising GCC Concern
HTG-AP is increasing in GCC in parallel with the metabolic syndrome epidemic. TG >11.3 mmol/L (1000 mg/dL) is sufficient to cause AP independently. Can be severe with higher recurrence risk.
Acute Management of HTG-AP
- Target TG <5.6 mmol/L (500 mg/dL) as initial goal
- Insulin infusion 0.1–0.3 units/kg/hr (activates lipoprotein lipase) — hourly BGL monitoring
- Heparin IV (100 units/kg bolus) then infusion — adjunct to activate LPL
- Strict NBM — removes dietary fat load
- Daily fasting lipid panel until TG <5.6 mmol/L
- Plasma exchange for TG >22.6 mmol/L or refractory cases
Long-Term Prevention (Nurse Education Role)
- Fibrates (fenofibrate) — first-line for hypertriglyceridaemia
- Omega-3 fatty acids (high-dose prescription) as adjunct
- Strict low-fat, low-carbohydrate diet — avoid simple sugars
- Alcohol abstinence — major TG driver
- Tight diabetes control — hyperglycaemia worsens HTG
- Weight reduction 5–10% reduces TG by 20–30%
- Avoid drugs that raise TG: beta-blockers, thiazides, oestrogens
🌙Ramadan Fasting — Chronic Pancreatitis Management
Clinical importance: Muslim patients with CP who wish to fast during Ramadan require individualised assessment and specific counselling. Blanket advice to "not fast" is culturally insensitive and often non-concordant.
PERT Timing During Ramadan
S
Suhoor (pre-dawn meal)
Full PERT dose with this meal — it may be the larger meal. Creon 25,000–50,000 units. PPI taken 30 min before.
I
Iftar (breaking fast at sunset)
Full PERT dose when breaking fast. Begin with dates + soup (traditional), then main meal — PERT taken at start of main meal.
N
Night meal (if taken)
Half PERT dose if snack, full dose if substantial meal. Typically 2–3h after Iftar.
Patients with stable CP, no active flares, good glycaemic control, and no significant malnutrition may be medically cleared to fast with close monitoring.
Risks During Ramadan Fasting in CP/AP
- Gallstone formation: Prolonged fasting leads to bile sludge and increased cholesterol supersaturation — risk of new stones
- Hypoglycaemia: Type 3c DM patients — glucagon deficiency + prolonged fasting = dangerous hypoglycaemia. Monitor pre-Iftar BGL.
- Dehydration: Particularly in summer Ramadan (GCC heat). Encourage adequate fluid intake at Iftar-Suhoor window.
- Medication timing disruption — review all medications with pharmacist
- Pancreatitis flares more common if dietary indiscretion at Iftar (large, high-fat meal)
Exemptions to Discuss Sensitively
- Active AP episode — fasting contraindicated
- T3cDM with recurrent hypoglycaemia — significant risk
- Severe malnutrition — fasting prohibited in Islam under medical necessity
- Consult religious scholar (fatwa) if patient concerned — Islam permits breaking fast for medical necessity
🏨Endoscopy Services in GCC
Service Availability
- Major tertiary centres (KFSH&RC, Cleveland Clinic Abu Dhabi, HMC Qatar, KKH) offer advanced EUS, ERCP, endoscopic necrosectomy
- LAMS (lumen-apposing metal stent) technology available in most tertiary GCC centres
- Smaller hospitals may require transfer — establish transfer pathways
- On-call ERCP availability varies — know your hospital's protocol
- Interventional radiology for PCD widely available in tertiary centres
Practical Considerations
- Consent process — ensure Arabic translation of consent forms where required
- Female patients may prefer female endoscopist if available — document and facilitate
- Fasting requirements during Ramadan — coordinate with Ramadan-modified procedure lists
- Expat patients — travel insurance, NOC (no-objection certificate) for complex procedures
🌐Patient Education — Arabic-Speaking Patients
PERT Education Key Points (Arabic Context)
- Explain concept: "البنكرياس لا يصنع إنزيمات كافية لهضم الطعام" — pancreas not making enough enzymes to digest food
- Capsules contain pork-derived enzymes (porcine pancrelipase) — must address proactively: medical necessity permits use in Islam (fatwa available); alternative bovine-derived products if patient requests
- Emphasise timing: "مع الأكلة مباشرةً" — with the meal directly
- Do not stop without medical advice — malnutrition risk
- Written Arabic instruction sheets — prepare and laminate for ward use
Dietary Advice — Culturally Adapted Low-Fat
- Reduce: samn (ghee/clarified butter), kabsa with fat-heavy rice, harees with butter
- Cooking methods: grilled or baked over fried
- Lean meats: chicken breast, fish over mutton/camel fat
- Limit dates at Iftar to 2–3 (high sugar, can worsen HTG)
- Vegetable-based dishes: fattoush, tabbouleh, lentil soups are excellent
- Small, frequent meals — avoid large Iftar/wedding feast volumes
- Dietitian referral with Arabic language capability where available